Tranexamic acid for joint inflammation and cartilage health after ACL injury
Tests tranexamic acid on joint inflammation in young adults with torn ACL.
Key facts
- Who runs it
- Stanford University
- Where
- Stanford, United StatesSee the site
- Trial code
- Registry title
- The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
- Status
- Recruiting
- Phase
- Phase 2
- People taking part
- 50 people, planned
- Started
- 1 Aug 2019
- Expected to end
- 14 Jan 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Tranexamic Acid
- Placebos
- Record updated
- 27 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young adults who tore the ACL (a main knee ligament) in one knee within the last 4 days and will have ACL repair surgery. It tests whether tranexamic acid lowers joint swelling and protects the cartilage.
- Age
- 18 to 30 years
- Sex
- All sexes
- Disease stage
- ACL tear in one knee within 4 days, with fluid or blood in the knee joint. People must be able to have ACL reconstruction surgery within 3 months of the injury.
- Earlier treatment
- No prior surgery on either knee. No cortisone injection into either knee in the prior 3 months. No long-term use of NSAID pain medicines.
Main reasons for not taking part
- Inflammatory arthritis, gout or pseudogout, or osteoarthritis seen on X-ray (K-L Grade 2 or higher)
- Other knee injuries, except a meniscus tear or an MCL tear that does not need surgery
- Earlier injury to either knee that needed crutches
- History of blood clots (thromboembolic disease)
- Current use of combination hormonal birth control
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- age 18-30 years
- within 4 days of unilateral ACL injury
- presence of effusion/hemarthrosis
Who cannot take part
- concomitant knee injury aside from meniscus tear and MCL tear not requiring surgery
- prior surgery to either knee
- prior injury to either knee requiring crutches
- cortisone injection to either knee within the prior 3 months
- systemic or acute illness requiring medications
- history of thromboembolic disease
- inflammatory arthritis, radiographic osteoarthritis (K-L Grade 2 or higher), gout/ pseudogout
- current use of combination hormonal contraception
- chronic NSAID use
- not indicated for or unable to undergo ACLR within 3 months of injury
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 30 years old?
Where in United States
- Stanford UniversityStanford, United StatesContact: Christine HoangTaking people
About the trial
What the trial wants to find out
Patients who tear their ACL are at high risk for developing arthritis (post-traumatic osteoarthritis-PTOA) just 10 years later. Joint bleeding and inflammation contribute to deterioration of joint health. This study will determine whether treatment with Tranexamic Acid (TXA), an FDA approved medication that reduces bleeding right after ACL injury and reconstructive surgery reduces inflammation and improves joint health as a new strategy to prevent or delay the onset of PTOA.
The 2 groups in the trial
- Tranexamic AcidTreatment being tested
5-day course of standard adult oral tranexamic acid dosage of 1300 mg taken 3 times a day (3900 mg/day) and intravenous tranexamic acid during ACL reconstruction surgery (1 gram of iv TXA just prior to incision and 1 gram of iv TXA just prior to wound closure)
- PlaceboPlacebo, for comparison
5-day course of placebo and intravenous saline during ACL reconstruction surgery
Treatment: Placebos
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Novel Strategies to Combat Post-Traumatic Osteoarthritis (PTOA):The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
- Plain-language title
- Tranexamic acid for joint inflammation and cartilage health after ACL injuryGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT03552705, who can take part
- Record updated
- 27 February 2026